IDENTIFICATION OF POTENT BROMODOMAIN4 (BRD4) INHIBITORS BY ENERGY-PHARMACOPHORE BASED VIRTUAL SCREENING TO TARGET BRD4-NUT MIDLINE CARCINOMA

Abstract

Objective: Protein-protein interactions (PPI’s) have been used as a target in various diseases. One such major role of PPI’s comes when the protein Bromodomain4 (BRD4) reads the epigenetic changes in the histones and regulates transcription. This protein has been shown by various research groups to be linked to a rare form of cancer called BRD4-NUT midline carcinoma. The present study incorporates understanding the role of BRD4 in such cancer and as is directed towards finding new lead compounds to target the PPI involved.Methods: To find potential lead molecules against BRD4 protein, contact based and e-pharmacophore based virtual screening studies approach was adopted with the use of PHASE and E-pharmacophore module of the Schrödinger Maestro tool. Based on the pharmacophore hypothesis developed, virtual screening was performed for 22, 70, 000 Clean Lead-like compounds from the ZINC database by Virtual Screening Workflow of Schrödinger Maestro. Further Molecular dynamics simulations by GROMACS 4.5.5 were performed to study the energetics and stability of the top most docked ligands with BRD4 protein.Results: Pharmacophore based virtual screening studies results in the retrieval of three potential lead molecules, ZINC68155904, ZINC67910065, and ZINC6710456 from ZINC database which interacts with BRD4 protein with Glide score of-9.98,-8.31,-7.61 kJ/mol respectively. The desired interaction of this ligands with Asn140, Pro82 and Tyr 97 of BRD4 protein showed that the final hits have the potency of forming a stable complex. Molecular dynamics simulations studies also support the stability of the BRD4-ligand docked complex.Conclusion: The above study shows three compounds obtained viz ZINC68155904, ZINC67910065, and ZINC6710456 may serve as potential lead compounds which can act against BRD4 protein. 

Authors and Affiliations

Sapam Tuleshwori Devi, Himani Tandon, Dinakara Rao Ampasala

Keywords

Related Articles

STUDY ON ANTIMYCOBACTERIAL ACTIVITY OF MARINE ACTINOMYCETES FROM COROMONDAL COASTAL REGION OF SOUTHERN INDIA

Objective: The objective of the present study is to screen the novel actinomycetes from marine sediment active against mycobacterium sp.Methods: actinomycetes were isolated by crowded plate technique and its antimycobact...

THE INFLUENCE OF EDUCATION OF DRUG INFORMATION BY PHARMACIST ON THE IMPROVEMENT OF KNOWLEDGE AND THERAPEUTIC TARGET TO TYPE 2 DIABETES MELLITUS OUTPATIENTS IN HOSPITAL

Objective: The study aims to determine the influence of education of drug information by the pharmacist on the improvement of knowledge and therapeutic target to type 2 diabetes mellitus outpatients in Dr. Moewardi Surak...

DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPTLC METHOD FOR DETERMINATION OF DARUNAVIR ETHANOLATE AND RITONAVIR

Objective: To develop and validate a new simple, accurate, precise and selective stability-indicating high performance thin layer chromatographic (HPTLC) method for simultaneous estimation of Darunavir ethanolate and Rit...

RP-UFLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CLOPIDOGREL, PANTOPRAZOLE AND ROSUVASTATIN IN HUMAN PLASMA: DRUG INTERACTION STUDIES

Objectives: Objective of our present study was to develop a novel ultra fast liquid chromatographic method for quantitative simultaneous estimation of Clopidogrel, Pantoprazole & Rosuvastatin in human plasma and to v...

PHARMACOGNOSTIC STUDY OF CALLISTEMON CITRINUS L. BARK

Objective: Pharmacognostic study of Callistemon citrinus L. barkMethods: The bark of Callistemon citrinus L. was shade dried and powdered mechanically. The powdered material was used for further Pharmacognostic study. Th...

Download PDF file
  • EP ID EP578848
  • DOI -
  • Views 53
  • Downloads 0

How To Cite

Sapam Tuleshwori Devi, Himani Tandon, Dinakara Rao Ampasala (2015). IDENTIFICATION OF POTENT BROMODOMAIN4 (BRD4) INHIBITORS BY ENERGY-PHARMACOPHORE BASED VIRTUAL SCREENING TO TARGET BRD4-NUT MIDLINE CARCINOMA. International Journal of Pharmacy and Pharmaceutical Sciences, 7(4), 77-84. https://europub.co.uk/articles/-A-578848